Search research articles
Contact Us
Filters
Showing results (651-660 of 1,025) with videos related to
Page
of 103
Sort By:
JAMA
|
November 24, 1999
Clinical and angiographic characteristics of exertion-related acute myocardial infarction
S Giri, P D Thompson, F J Kiernan, et al.
NMR in Biomedicine
|
July 11, 2020
Nitroxide-enhanced MRI of cardiovascular oxidative stress
Soham A Shah, Sophia X Cui, Christopher D Waters, et al.
JAMA
|
April 13, 2001
Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial
G G Schwartz, A G Olsson, M D Ezekowitz, et al.
Journal of the American College of Cardiology
|
November 7, 2006
Effects of high-dose atorvastatin on cerebrovascular events in patients with stable coronary disease in the TNT (treating to new targets) study
David D Waters, John C LaRosa, Philip Barter, et al.
Evolutionary Applications
|
June 22, 2018
Genomewide association analyses of fitness traits in captive-reared Chinook salmon: Applications in evaluating conservation strategies
Charles D Waters, Jeffrey J Hard, Marine S O Brieuc, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology
|
January 1, 1995
Safety of dipyridamole testing in 73,806 patients: the Multicenter Dipyridamole Safety Study
J Lette, J L Tatum, S Fraser, et al.
Circulation
|
April 6, 2018
Triglyceride-Rich Lipoprotein Cholesterol and Risk of Cardiovascular Events Among Patients Receiving Statin Therapy in the TNT Trial
Antonio J Vallejo-Vaz, Rana Fayyad, S Matthijs Boekholdt, et al.
The American Journal of Cardiology
|
March 31, 2012
Relation of improvement in estimated glomerular filtration rate with atorvastatin to reductions in hospitalizations for heart failure (from the Treating to New Targets [TNT] study)
Jennifer E Ho, David D Waters, Allison Kean, et al.
Journal of the American College of Cardiology
|
May 17, 2008
Intensive lipid-lowering with atorvastatin for secondary prevention in patients after coronary artery bypass surgery
Sanjiv J Shah, David D Waters, Philip Barter, et al.
The American Journal of Cardiology
|
March 4, 2014
Impact of high-dose atorvastatin therapy and clinical risk factors on incident aortic valve stenosis in patients with cardiovascular disease (from TNT, IDEAL, and SPARCL)
Benoit J Arsenault, S Matthijs Boekholdt, Samia Mora, et al.
Page
of 103
Search research articles
Search
Showing results (651-660 of 1,025) with videos related to
Sort By:
Page
of 103
JAMA
|
November 24, 1999
Clinical and angiographic characteristics of exertion-related acute myocardial infarction
S Giri, P D Thompson, F J Kiernan, et al.
NMR in Biomedicine
|
July 11, 2020
Nitroxide-enhanced MRI of cardiovascular oxidative stress
Soham A Shah, Sophia X Cui, Christopher D Waters, et al.
JAMA
|
April 13, 2001
Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial
G G Schwartz, A G Olsson, M D Ezekowitz, et al.
Journal of the American College of Cardiology
|
November 7, 2006
Effects of high-dose atorvastatin on cerebrovascular events in patients with stable coronary disease in the TNT (treating to new targets) study
David D Waters, John C LaRosa, Philip Barter, et al.
Evolutionary Applications
|
June 22, 2018
Genomewide association analyses of fitness traits in captive-reared Chinook salmon: Applications in evaluating conservation strategies
Charles D Waters, Jeffrey J Hard, Marine S O Brieuc, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology
|
January 1, 1995
Safety of dipyridamole testing in 73,806 patients: the Multicenter Dipyridamole Safety Study
J Lette, J L Tatum, S Fraser, et al.
Circulation
|
April 6, 2018
Triglyceride-Rich Lipoprotein Cholesterol and Risk of Cardiovascular Events Among Patients Receiving Statin Therapy in the TNT Trial
Antonio J Vallejo-Vaz, Rana Fayyad, S Matthijs Boekholdt, et al.
The American Journal of Cardiology
|
March 31, 2012
Relation of improvement in estimated glomerular filtration rate with atorvastatin to reductions in hospitalizations for heart failure (from the Treating to New Targets [TNT] study)
Jennifer E Ho, David D Waters, Allison Kean, et al.
Journal of the American College of Cardiology
|
May 17, 2008
Intensive lipid-lowering with atorvastatin for secondary prevention in patients after coronary artery bypass surgery
Sanjiv J Shah, David D Waters, Philip Barter, et al.
The American Journal of Cardiology
|
March 4, 2014
Impact of high-dose atorvastatin therapy and clinical risk factors on incident aortic valve stenosis in patients with cardiovascular disease (from TNT, IDEAL, and SPARCL)
Benoit J Arsenault, S Matthijs Boekholdt, Samia Mora, et al.
Page
of 103